Hinge Health, Inc. cash flow statement
In fiscal 2025, Hinge Health, Inc.'s operations generated $171m of cash; it spent $708,000 on capital projects, leaving free cash flow of $171m. It returned $65.0m through buybacks.
Cash flow statement
| Fiscal year | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 | LTMJun 2026 |
|---|---|---|---|---|
| Cash from operations | −64 | 49 | 171 | 291 |
| Depreciation and amortisation | 6 | 6 | 5 | 3 |
| Stock-based pay | 2 | 1 | 643 | 83 |
| Capital spending | 2 | 1 | 1 | 1 |
| Free cash flow | −66 | 48 | 171 | 290 |
| Free cash flow after stock pay | −68 | 47 | −472 | 207 |
| Share buybacks | 0 | 0 | 65 | — |
| Shares issued | 0 | 0 | 8 | — |
| Quarter | 2024 Q3Sept 2024 | 2024 Q4Dec 2024 | 2025 Q1Mar 2025 | 2025 Q2Jun 2025 | 2025 Q3Sept 2025 | 2025 Q4Dec 2025 | 2026 Q1Mar 2026 | 2026 Q2Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | 28 | 38 | 5 | 20 | 82 | 64 | 43 | 101 |
| Depreciation and amortisation | 1 | 1 | 1 | 0 | 0 | 1 | 1 | 0 |
| Stock-based pay | 0 | 0 | 0 | 591 | 35 | 17 | 12 | 19 |
| Capital spending | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Free cash flow | 28 | 38 | 5 | 20 | 82 | 63 | 43 | 101 |
| Free cash flow after stock pay | 28 | 38 | 5 | −571 | 47 | 46 | 31 | 82 |
Compare with peers
- Goodrx Holdings, Inc. cash flow
- Doximity, Inc. cash flow
- Phreesia, Inc. cash flow
- Genedx Holdings Corp. cash flow
- Omnicell, Inc. cash flow
Head to head: GDRX vs HNGEDOCS vs HNGEHNGE vs PHR
More: Health Care Technology stocks compared, Health Care sector, rankings of US companies